Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance Program
作者： M. A. Pfaller , L. B. Boyken , R. J. Hollis , J. Kroeger , S. A. Messer
DOI: 10.1128/JCM.02437-10
关键词: Microbiology 、 Antifungal 、 Cutoff 、 Posaconazole 、 Candida spp 、 Serial dilution 、 Voriconazole 、 Broth microdilution 、 Medicine
摘要: We performed 24- and 48-h MIC determinations of posaconazole voriconazole against more than 16,000 clinical isolates Candida species. By using the epidemiological cutoff values (ECVs), categorical agreement between 24-h reference broth microdilution results ranged from 97.1% (C. parapsilosis voriconazole) to 99.8% krusei voriconazole), with 0.0 2.9% very major discrepancies (VMD). The essential (within 2 log2 dilutions) was 99.6% for both voriconazole. obtained after only 24 h incubation may be used determine susceptibilities spp. these important antifungal agents. applications ECVs this large collection suggests potential develop species-specific breakpoints
sci-hub.se 参考文章(38)
M. C. Arendrup, D. W. Denning, M. A. Pfaller, D. J. Diekema, J. H. Rex, Does one voriconazole breakpoint suit all Candida species Journal of Clinical Microbiology. ,vol. 45, pp. 2093- 2094 ,(2007) , 10.1128/JCM.00412-07
S. Hadley, Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients Journal of Antimicrobial Chemotherapy. ,vol. 49, pp. 415- 419 ,(2002) , 10.1093/JAC/49.2.415
Michael D. Parkins, Deana M. Sabuda, Sameer Elsayed, Kevin B. Laupland, Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections Journal of Antimicrobial Chemotherapy. ,vol. 60, pp. 613- 618 ,(2007) , 10.1093/JAC/DKM212
Matthew Morrell, Victoria J. Fraser, Marin H. Kollef, Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality Antimicrobial Agents and Chemotherapy. ,vol. 49, pp. 3640- 3645 ,(2005) , 10.1128/AAC.49.9.3640-3645.2005
M. A. Pfaller, D. J. Diekema, J. H. Rex, A. Espinel-Ingroff, E. M. Johnson, D. Andes, V. Chaturvedi, M. A Ghannoum, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, P. Troke, T. J. Walsh, D. W. Warnock, Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints Journal of Clinical Microbiology. ,vol. 44, pp. 819- 826 ,(2006) , 10.1128/JCM.44.3.819-826.2006
F. Sabatelli, R. Patel, P. A. Mann, C. A. Mendrick, C. C. Norris, R. Hare, D. Loebenberg, T. A. Black, P. M. McNicholas, In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrobial Agents and Chemotherapy. ,vol. 50, pp. 2009- 2015 ,(2006) , 10.1128/AAC.00163-06
Ana Espinel-Ingroff, E Canton, J Peman, MG Rinaldi, AW Fothergill, None, Comparison of 24-Hour and 48-Hour Voriconazole MICs as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 Document) in Three Laboratories: Results Obtained with 2,162 Clinical Isolates of Candida spp. and Other Yeasts Journal of Clinical Microbiology. ,vol. 47, pp. 2766- 2771 ,(2009) , 10.1128/JCM.00654-09
Luis Ostrosky-Zeichner, John H. Rex, Michael A. Pfaller, Daniel J. Diekema, Barbara D. Alexander, David Andes, Steven D. Brown, Vishnu Chaturvedi, Mahmoud A. Ghannoum, Cindy C. Knapp, Daniel J. Sheehan, Thomas J. Walsh, Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method Antimicrobial Agents and Chemotherapy. ,vol. 52, pp. 4175- 4177 ,(2008) , 10.1128/AAC.00420-08
Gunnar Kahlmeter, Derek FJ Brown, Fred W Goldstein, Alasdair P MacGowan, Johan W Mouton, Anders Österlund, Arne Rodloff, Martin Steinbakk, Pavla Urbaskova, Alkiviadis Vatopoulos, European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria Journal of Antimicrobial Chemotherapy. ,vol. 52, pp. 145- 148 ,(2003) , 10.1093/JAC/DKG312
Peter G. Pappas, Carol A. Kauffman, David Andes, Daniel K. Benjamin, Jr., Thierry F. Calandra, John E. Edwards, Jr., Scott G. Filler, John F. Fisher, Bart‐Jan Kullberg, Luis Ostrosky‐Zeichner, Annette C. Reboli, John H. Rex, Thomas J. Walsh, Jack D. Sobel, Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. ,vol. 48, pp. 503- 535 ,(2009) , 10.1086/596757